Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-24
DOI
10.3389/fonc.2020.01027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies
- (2020) Federica Eduati et al. Molecular Systems Biology
- Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
- (2020) Sohyun Hwang et al. Scientific Reports
- Integrative network modeling reveals mechanisms underlying T cell exhaustion
- (2020) Hamid Bolouri et al. Scientific Reports
- Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes
- (2020) Tianshi Lu et al. Science Immunology
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment
- (2019) Kerri-Ann Norton et al. Processes
- Personalization of Logical Models With Multi-Omics Data Allows Clinical Stratification of Patients
- (2019) Jonas Béal et al. Frontiers in Physiology
- Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
- (2019) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
- (2019) Alexander C. Huang et al. NATURE MEDICINE
- 3D models in the new era of immune oncology: focus on T cells, CAF and ECM
- (2019) Francesca Di Modugno et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
- (2019) Tina Gruosso et al. JOURNAL OF CLINICAL INVESTIGATION
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- Prognostic value of B cells in cutaneous melanoma
- (2019) Sara R. Selitsky et al. Genome Medicine
- In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
- (2019) Hanwen Wang et al. Royal Society Open Science
- RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia/lymphoma
- (2019) Amir Farmanbar et al. npj Genomic Medicine
- Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
- (2019) Michael J. Duffy et al. CLINICAL CHEMISTRY
- Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures
- (2019) Konstantin Zaitsev et al. Nature Communications
- Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
- (2019) Kirill Peskov et al. Frontiers in Immunology
- Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
- (2019) Sanjeevani Arora et al. ADVANCES IN THERAPY
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- (2019) Nicolas Jacquelot et al. CELL RESEARCH
- The Immune Landscape of Cancer
- (2019) Vésteinn Thorsson et al. IMMUNITY
- Next-generation computational tools for interrogating cancer immunity
- (2019) Francesca Finotello et al. NATURE REVIEWS GENETICS
- A Quantitative Multivariate Model of Human Dendritic Cell-T Helper Cell Communication
- (2019) Maximilien Grandclaudon et al. CELL
- A multiscale signalling network map of innate immune response in cancer reveals cell heterogeneity signatures
- (2019) Maria Kondratova et al. Nature Communications
- NicheNet: modeling intercellular communication by linking ligands to target genes
- (2019) Robin Browaeys et al. NATURE METHODS
- Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug
- (2019) D. Perlstein et al. PLoS One
- Quantifying tumor-infiltrating immune cells from transcriptomics data
- (2018) Francesca Finotello et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer
- (2018) Valeria Quaranta et al. CANCER RESEARCH
- High-throughput screening of combinatorial immunotherapies with patient-specific in silico models of metastatic colorectal cancer
- (2018) Jakob Nikolas Kather et al. CANCER RESEARCH
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- A microfluidics platform for combinatorial drug screening on cancer biopsies
- (2018) Federica Eduati et al. Nature Communications
- Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
- (2018) Joel Saltz et al. Cell Reports
- Modeling Cell-to-Cell Communication Networks Using Response-Time Distributions
- (2018) Kevin Thurley et al. Cell Systems
- Association of high tissue TMB and atezolizumab efficacy across multiple tumor types.
- (2018) Fatema A. Legrand et al. JOURNAL OF CLINICAL ONCOLOGY
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- OUP accepted manuscript
- (2018) NUCLEIC ACIDS RESEARCH
- Mathematical modeling identifies Lck as a potential mediator for PD-1 induced inhibition of early TCR signaling
- (2018) Theinmozhi Arulraj et al. PLoS One
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
- (2018) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
- (2018) Noam Auslander et al. NATURE MEDICINE
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer
- (2018) Jin-Huan Cui et al. Frontiers in Immunology
- Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
- (2018) Francesca Finotello et al. Frontiers in Oncology
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment
- (2017) Thomas Worzfeld et al. MOLECULAR & CELLULAR PROTEOMICS
- The benefits of immunotherapy combinations
- (2017) Charles Schmidt NATURE
- Making cancer immunotherapy a surer bet
- (2017) Michael Eisenstein NATURE
- Chromatin states define tumour-specific T cell dysfunction and reprogramming
- (2017) Mary Philip et al. NATURE
- Functional precision cancer medicine—moving beyond pure genomics
- (2017) Anthony Letai NATURE MEDICINE
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
- (2017) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
- (2017) Chan-Young Ock et al. Nature Communications
- TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
- (2017) Florie Bertrand et al. Nature Communications
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- A Dynamic Model of Immune Responses to Antigen Presentation Predicts Different Regions of Tumor or Pathogen Elimination
- (2017) Eduardo D. Sontag Cell Systems
- Drug screening of cancer cell lines and human primary tumors using droplet microfluidics
- (2017) Ada Hang-Heng Wong et al. Scientific Reports
- Abstract 4363: Loss of PTEN promotes resistance to T cell-mediated immunotherapy
- (2016) Weiyi Peng et al. CANCER RESEARCH
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- OmniPath: guidelines and gateway for literature-curated signaling pathway resources
- (2016) Dénes Türei et al. NATURE METHODS
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire
- (2016) Jennifer S. Sims et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The epigenetic landscape of T cell exhaustion
- (2016) D. R. Sen et al. SCIENCE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells
- (2016) Amelia J. Tesone et al. Cell Reports
- Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy
- (2016) D. B. Page et al. Cancer Immunology Research
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
- (2015) N. A. Giraldo et al. CLINICAL CANCER RESEARCH
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
- (2015) D. Fey et al. Science Signaling
- A draft network of ligand–receptor-mediated multicellular signalling in human
- (2015) Jordan A. Ramilowski et al. Nature Communications
- Transcriptome Analysis of Individual Stromal Cell Populations Identifies Stroma-Tumor Crosstalk in Mouse Lung Cancer Model
- (2015) Hyejin Choi et al. Cell Reports
- Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
- (2015) D. Fey et al. Science Signaling
- Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
- (2014) David Quigley et al. MOLECULAR CANCER RESEARCH
- Multiplexed ion beam imaging of human breast tumors
- (2014) Michael Angelo et al. NATURE MEDICINE
- Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
- (2014) Charlotte Giesen et al. NATURE METHODS
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- (2013) Felix Klug et al. CANCER CELL
- Interleukin 21-Induced Granzyme B-Expressing B Cells Infiltrate Tumors and Regulate T Cells
- (2013) S. Lindner et al. CANCER RESEARCH
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
- (2012) Jane L. Messina et al. Scientific Reports
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started